Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.
Up next
Author


The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare and Medicaid beneficiaries and to users of TrumpRx.gov, the administration’s new direct-to-consumer website.

You May Also Like
Retail sales climb again ahead of holiday shopping season. U.S. economy still has momentum.

Retail sales climb again ahead of holiday shopping season. U.S. economy still has momentum.

Sales at retailers rose solidly in October and suggested the economy still…

Labour left with ‘catastrophic’ Tory spending inheritance, says minister

Chancellor Rachel Reeves will on Monday confront a “catastrophic” spending inheritance from…
It’s a terrible time to quit your job — except in these 3 cases

It’s a terrible time to quit your job — except in these 3 cases

Workers can “go wild” if they’re looking for a new job in…
Opinion: Look out, Super Micro: Dell is cementing itself as an AI play too

Opinion: Look out, Super Micro: Dell is cementing itself as an AI play too

Look out, Super Micro investors, as Dell is starting to cement itself…